{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:25:23Z","timestamp":1762161923117,"version":"3.37.3"},"reference-count":18,"publisher":"Japan Endocrine Society","issue":"1","funder":[{"name":"Health Labour Sciences Research Grant","award":["23FC1042"],"award-info":[{"award-number":["23FC1042"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1507\/endocrj.ej24-0344","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T22:10:21Z","timestamp":1729721421000},"page":"93-102","source":"Crossref","is-referenced-by-count":1,"title":["Mutual associations among responsiveness to differential diagnostic tests for Cushing\u2019s disease, tumor size, and somatostatin receptor 5 expression in corticotroph tumors"],"prefix":"10.1507","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6389-6701","authenticated-orcid":false,"given":"Karolina","family":"Budzen","sequence":"first","affiliation":[{"name":"Departments of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9365-5561","authenticated-orcid":false,"given":"Kosuke","family":"Mukai","sequence":"additional","affiliation":[{"name":"Departments of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Mitsui","sequence":"additional","affiliation":[{"name":"Departments of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5947-8621","authenticated-orcid":false,"given":"Michio","family":"Otsuki","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Tokyo Women\u2019s Medical University Graduate School of Medical Science, Tokyo 162-8666, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6289-3778","authenticated-orcid":false,"given":"Atsunori","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Departments of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"},{"name":"Department of Adipose Management, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4248-2322","authenticated-orcid":false,"given":"Satoru","family":"Oshino","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1647-3721","authenticated-orcid":false,"given":"Youichi","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Tokuyukai Rehabilitation Clinic, Osaka 560-0083, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7636-5833","authenticated-orcid":false,"given":"Masaharu","family":"Kohara","sequence":"additional","affiliation":[{"name":"Pathology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8490-3650","authenticated-orcid":false,"given":"Eiichi","family":"Morii","sequence":"additional","affiliation":[{"name":"Pathology, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0851-9603","authenticated-orcid":false,"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Departments of Metabolic Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Ntali G, Grossman A, Karavitaki N (2015) Clinical and biochemical manifestations of Cushing\u2019s. Pituitary 18: 181\u2013187.","DOI":"10.1007\/s11102-014-0631-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Woo YS, Isidori AM, Wat WZ, Kaltsas GA, Afshar F, et al. (2005) Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas. J Clin Endocrinol Metab 90: 4963\u20134969.","DOI":"10.1210\/jc.2005-0070"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Albani A, Perez-Rivas LG, Tang S, Simon J, Lucia KE, et al. (2022) Improved pasireotide response in <i>USP8<\/i> mutant corticotroph tumours <i>in vitro<\/i>. Endocr Relat Cancer 29: 503\u2013511.","DOI":"10.1530\/ERC-22-0088"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Hayashi K, Inoshita N, Kawaguchi K, Ibrahim Ardisasmita A, Suzuki H, et al. (2016) The <i>USP8<\/i> mutational status may predict drug susceptibility in corticotroph adenomas of Cushing\u2019s disease. Eur J Endocrinol 174: 213\u2013226.","DOI":"10.1530\/EJE-15-0689"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5 Shichi H, Fukuoka H, Kanzawa M, Yamamoto M, Yamamoto N, et al. (2022) Responsiveness to DDAVP in Cushing\u2019s disease is associated with <i>USP8<\/i> mutations through enhancing <i>AVPR1B<\/i> promoter activity. Pituitary 25: 496\u2013507.","DOI":"10.1007\/s11102-022-01220-4"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Atquet V, Alexopoulou O, Maiter D (2021) Characteristics and treatment responsiveness of patients with acromegaly and a paradoxical GH increase to oral glucose load. Eur J Endocrinol 185: 313\u2013321.","DOI":"10.1530\/EJE-21-0324"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Mukai K, Otsuki M, Tamada D, Kitamura T, Hayashi R, et al. (2019) Clinical characteristics of acromegalic patients with paradoxical GH response to oral glucose load. J Clin Endocrinol Metab 104: 1637\u20131644.","DOI":"10.1210\/jc.2018-00975"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Arita H, Kinoshita M, Oshino S, Kitamura T, Otsuki M, et al. (2012) Biological characteristics of growth hormone-producing pituitary adenomas are different according to responsiveness to thyrotropin-releasing hormone. J Clin Endocrinol Metab 97: 2741\u20132747.","DOI":"10.1210\/jc.2012-1125"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Kageyama K, Oki Y, Sakihara S, Nigawara T, Terui K, et al. (2013) Evaluation of the diagnostic criteria for Cushing\u2019s disease in Japan. Endocr J 60: 127\u2013135.","DOI":"10.1507\/endocrj.EJ12-0299"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Selek A, Cetinarslan B, Canturk Z, Tarkun I, Akyay OZ, et al. (2018) The utility of preoperative ACTH\/cortisol ratio for the diagnosis and prognosis of Cushing\u2019s disease. J Neurosci Rural Pract 9: 106\u2013111.","DOI":"10.4103\/jnrp.jnrp_308_17"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Lupp A, Hunder A, Petrich A, Nagel F, Doll C, et al. (2011) Reassessment of sst(5) somatostatin receptor expression in normal and neoplastic human tissues using the novel rabbit monoclonal antibody UMB-4. Neuroendocrinology 94: 255\u2013264.","DOI":"10.1159\/000329876"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Wang FF, Tang KT, Yen YS, Ho DM, Yang AH, et al. (2012) Plasma corticotrophin response to desmopressin in patients with Cushing\u2019s disease correlates with the expression of vasopressin receptor 2, but not with that of vasopressin receptor 1 or 3, in their pituitary tumours. Clin Endocrinol 76: 253\u2013263.","DOI":"10.1111\/j.1365-2265.2011.04179.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Gatto F, Arvigo M, Ferone D (2020) Somatostatin receptor expression and patients\u2019 response to targeted medical treatment in pituitary tumors: evidences and controversies. J Endocrinol Invest 43: 1543\u20131553.","DOI":"10.1007\/s40618-020-01335-0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Ferrante E, Barbot M, Serban AL, Ceccato F, Carosi G, et al. (2022) Indication to dynamic and invasive testing in Cushing\u2019s disease according to different neuroradiological findings. J Endocrinol Invest 45: 629\u2013637.","DOI":"10.1007\/s40618-021-01695-1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Moreno-Moreno P, Ib\u00e1\u00f1ez-Costa A, Venegas-Moreno E, Fuentes-Fayos AC, Alhambra-Exp\u00f3sito MR, et al. (2022) Integrative clinical, radiological, and molecular analysis for predicting remission and recurrence of cushing disease. J Clin Endocrinol Metab 107: e2938\u2013e2951.","DOI":"10.1210\/clinem\/dgac172"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Murasawa S, Kageyama K, Sugiyama A, Ishigame N, Niioka K, et al. (2000) Inhibitory effects of SOM230 on adrenocorticotropic hormone production and corticotroph tumor cell proliferation <i>in vitro<\/i> and <i>in vivo<\/i>. Mol Cell Endocrinol 394: 37\u201346.","DOI":"10.1016\/j.mce.2014.07.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Treppiedi D, Di Muro G, Mangili F, Catalano R, Giardino E, et al. (2021) Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells. Mol Cell Endocrinol 524: 111159.","DOI":"10.1016\/j.mce.2021.111159"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Giuffrida G, Crisafulli S, Ferra\u00f9 F, Fontana A, Alessi Y, et al. (2022) Global Cushing\u2019s disease epidemiology: a systematic review and meta-analysis of observational studies. J Endocrinol Invest 45: 1235\u20131246.","DOI":"10.1007\/s40618-022-01754-1"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0344\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T03:35:07Z","timestamp":1736566507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/72\/1\/72_EJ24-0344\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0344","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"type":"print","value":"0918-8959"},{"type":"electronic","value":"1348-4540"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"EJ24-0344"}}